Disparities still persist in follow-up rates, with largest disparities seen between Black and White patients, Medicaid dual- versus non-dual-eligible
Oversight of DOAC Prescribing Beneficial for A-Fib, VTE Patients
Oversight identifies errors, especially in a-fib patients, who mainly have alerts for off-label prescribing during follow-up period